2001, I started to attend patients with acute pancreatitis as a GI resident in @GVAsalualicante. Books and papers recommended aggressive fluid resuscitation. It was believed that many fluids increased pancreatic blood flow preventing pancreatic necrosis
But I asked to myself, what is aggressive fluid resuscitation, how much fluids, and which type of fluids? I looked for specific data, but all was vague. I asked in GI meetings, and the answers of experts were vague, no specific fluid rate, just generalities
In 2005 I started being in charge of @GVAsalualicante pancreatic unit thanks to my boss Miguel Pérez-Mateo, my mentor. The question remained unanswered (and I was obsessed). 2 years later we started a prospective study on the effect of fluid volume on acute pancreatitis outcomes
This observational study showed that patients receiving the highest quartile of fluid volume had WORSE outcomes! It was published on @AmJGastro journals.lww.com/ajg/Abstract/2…
An editorial by Bechien Wu, “fluid resuscitation in acute pancreatitis: striking the right balance” remarked that the study challenged several of our long-held beliefs regarding the benefits of vigorous fluid resuscitation in acute pancreatitis journals.lww.com/ajg/Abstract/2…
Then we became interested in fluid sequestration as an important factor in fluid resuscitation, and a source of bias. In a collaborative study with my friend Vikesh Singh we described the determinants of fluid sequestration @AGA_CGHcghjournal.org/article/S1542-…
For me, this paper was my first collaborative study, my first international study, and an incredible experience, That year I had my first talk outside Spain in the @HopkinsGIHep GI course. This collaboration brought me that awesome experiences, thanks Vik, my friend
With all this experience we hypothesized a new model to understand fluid resuscitation in acute pancreatitis: the dynamic model published in @AGA_CGHcghjournal.org/article/S1542-…
Then we looked at fluid resuscitation at the very initial phase of acute pancreatitis: fluid boluses administered in the emergency room, we published this observational study on @UEGJournal Patients receiving more fluids did not have better outcomes onlinelibrary.wiley.com/doi/10.1177/20…
We focused then on the type of fluid resuscitation; in our first RCT we compared lactated Ringer solution vs normal saline, we described that Ringer was associated with an anti-inflammatory effect, as suggested by a previous RCT by B Wu in 2011 @UEGJournaljournals.sagepub.com/doi/10.1177/20…
In that paper my friend @nielo40 did some basic stuff to complement our single-center RCT on patients, and demonstrated that lactate from Ringer Lactate was the anti-inflammatory molecule, thanks Mestre! journals.sagepub.com/doi/10.1177/20…
But the old question remained unanswered,
How
much
fluids
should
we
administer
to
patients
with
acute
pancreatitis
?
In January 2019 I asked Federico Bolado from Pamplona, Spain and James Buxbaum from Los Angeles, USA to develop the #WATERFALLtrial as an international multicenter study to answer the critical question: does aggressive fluid resuscitation improve outcomes in acute pancreatitis
Look at this first email to James Buxbaum proposing he join the project, January 2019
Designing the study was a nightmare, we had to develop definitions of fluid overload, hypovolemia, to develop a very complex electronic case report… a real challenge
Thanks James and Federico! hundreds of emails...
My friends Pedro Zapater and Patrick Maissoneuve were in charge of statistics, they did a hard job! @Lguilabert1 was in charge of @GVAsalualicante patients and Alicia Vaillo coordinated the whole study, THANKS
This is the first email from @NEJM, I almost had a heart attack
👇
And this, the final one
The funny thing is that I received the final acceptance of WATERFALL while I was writing a Twitter thread about @HarvardMINT2022 @CharuParanjape@krishnanendo , look 👇
So, 21 years after a practical question, a step-by-step learning process, inspired by my mentors and clearly by the @pancreatitis_nl group @MarcBesselink, guys you are the soul of clinical research
Finally, we are particularly proud that we could do this @NEJM study from a 300,000 inhabitants city on the coast of Spain, in a Spanish public hospital, with public funds @SaludISCIII@isabial_iis@GVAsalualicante@aegastro
So,
you can also do it! Just choose the right question, and start to walk, step by step, no rush
Good night
2/5 Panther trial: A Step-up Approach or Open Necrosectomy for Necrotizing Pancreatitis @NEJM
This trial robustly demonstrated that minimally invasive treatment (percutaneous drainage and minim. invasive surgery if needed) was better than open surgery nejm.org/doi/10.1056/NE…
3/5 Penguin trial: Endoscopic Transgastric vs Surgical Necrosectomy for Infected Necrotizing Pancreatitis @JAMA_currentjamanetwork.com/journals/jama/… This trial showed that endoscopic necrosectomy was better (less aggressive) than open surgery
This special #TheAmylaseSchool infographics (or mini-course) is a guide to navigate the deep waters of Pubmed (and not get drown). I provide a pdf at the end of the Twitter Thread
1/5 Author Journal Date Title Abstract Language Affiliation
👇
How to search in Pubmed 2/5
Mesh terms, Boolean operators, My NCBI filters
👇
How to search in Pubmed 3/5
How to save your search
👇
The groove area or pancreaticoduodenal groove involves the space between the duodenum, the head of the pancreas and the common bile duct karger.com/Article/FullTe…
Groove pancreatitis is a segmental chronic pancreatitis that affects the groove area; it was described in 1973 by Becker link.springer.com/book/10.1007/9…
Cross-sectional imaging often reveals unexpected pancreatic cystic lesions, it is a frequent clinical problem, Should we observe or remove it? What's the diagnosis? Is our patient in danger of malignancy?
Don’t miss this @aegastro@my_ueg#EducAEG#UEGambassador twitter thread
Importance of Pancreatic Cystic Neoplasms (PCN):
Most are asymptomatic at diagnosis, frequency increases with age
Symptoms: acute pancreatitis (Wirsung obstructed by the cyst or mucus), pain, obstructive chronic pancreatitis, jaundice
> symptoms, >malignancy risk!
Classification of PCN:
Mucinous: intraductal papillary mucinous neop. and mucinous cystic neop.
Nonmucinous: serous cystic neoplasm, solid pseudopapillary neoplasm and cystic neuroendocrine tumours
Endoderm- derived columnar epithelium is characteristic for mucinous lesions
👇
For ancient physicians the most important feature of diabetes was the increased urine output. Diabetes was a term for polyuria derived from the classical Greek word "diabainein" meaning to walk with the legs apart, later diabetes "a passer through" or a "siphon".
The Greek physician Arateus (credited for the term Diabetes) described it as "the melting down of flesh and limbs into urine"